(3-nitrobenzoyl)alanine has been researched along with kynurenine in 6 studies
| Studies ((3-nitrobenzoyl)alanine) | Trials ((3-nitrobenzoyl)alanine) | Recent Studies (post-2010) ((3-nitrobenzoyl)alanine) | Studies (kynurenine) | Trials (kynurenine) | Recent Studies (post-2010) (kynurenine) |
|---|---|---|---|---|---|
| 15 | 0 | 3 | 4,137 | 115 | 2,031 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carpenedo, R; Chiarugi, A; Mattoli, L; Molina, MT; Moroni, F; Pellicciari, R | 1 |
| Carlà, V; Carpenedo, R; Chiarugi, A; Lombardi, G; Mattoli, L; Moroni, F; Pellicciari, R; Russi, P | 1 |
| Carpenedo, R; Chiarugi, A; Costantino, G; Mahmoud, MR; Mattoli, L; Moroni, F; Natalini, B; Pellicciari, R; Sadeghpour, BM | 1 |
| Chiarugi, A; Moroni, F; Rapizzi, E | 1 |
| Behan, WM; Stone, TW | 1 |
| Carpenedo, R; Meli, E; Moroni, F; Pellegrini-Giampietro, DE; Peruginelli, F | 1 |
6 other study(ies) available for (3-nitrobenzoyl)alanine and kynurenine
| Article | Year |
|---|---|
Comparison of the neurochemical and behavioral effects resulting from the inhibition of kynurenine hydroxylase and/or kynureninase.
Topics: Alanine; Animals; Anticonvulsants; Behavior, Animal; Drug Interactions; Extracellular Space; Hydrolases; Hypnotics and Sedatives; Kinetics; Kynurenic Acid; Kynurenine; Kynurenine 3-Monooxygenase; Male; Mixed Function Oxygenases; Quinolinic Acid; Rats; Rats, Wistar | 1995 |
Inhibitors of kynurenine hydroxylase and kynureninase increase cerebral formation of kynurenate and have sedative and anticonvulsant activities.
Topics: Alanine; Animals; Anticonvulsants; Brain Chemistry; Electroshock; Excitatory Amino Acid Antagonists; Hydrolases; Hypnotics and Sedatives; Kynurenic Acid; Kynurenine; Kynurenine 3-Monooxygenase; Male; Mixed Function Oxygenases; Motor Activity; Neuroglia; Niacin; ortho-Aminobenzoates; Quinolinic Acid; Rats; Rats, Wistar; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate | 1994 |
Modulation of the kynurenine pathway in search for new neuroprotective agents. Synthesis and preliminary evaluation of (m-nitrobenzoyl)alanine, a potent inhibitor of kynurenine-3-hydroxylase.
Topics: Alanine; Animals; Anticonvulsants; Binding, Competitive; Brain; Hippocampus; Hydrolases; Kynurenic Acid; Kynurenine; Kynurenine 3-Monooxygenase; Liver; Mixed Function Oxygenases; Models, Molecular; Molecular Structure; Motor Activity; Rats; Seizures; Tryptophan | 1994 |
The kynurenine metabolic pathway in the eye: studies on 3-hydroxykynurenine, a putative cataractogenic compound.
Topics: Alanine; Animals; Cataract; Ciliary Body; Eye; Hydrolases; Iris; Kynurenine; Kynurenine 3-Monooxygenase; Lens, Crystalline; Lyases; Male; Mixed Function Oxygenases; Rabbits; Sulfonamides; Thiazoles; Tissue Distribution; Transaminases; Tryptophan Oxygenase | 1999 |
Role of kynurenines in the neurotoxic actions of kainic acid.
Topics: Alanine; Animals; Dizocilpine Maleate; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glycine; Hippocampus; Kainic Acid; Kynurenine; Male; Quinolinic Acid; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate | 2000 |
Kynurenine 3-mono-oxygenase inhibitors attenuate post-ischemic neuronal death in organotypic hippocampal slice cultures.
Topics: Alanine; Animals; Brain Ischemia; Cell Death; Cell Hypoxia; Culture Media, Conditioned; Enzyme Inhibitors; Glucose; Hippocampus; In Vitro Techniques; Kynurenic Acid; Kynurenine; Kynurenine 3-Monooxygenase; Mixed Function Oxygenases; Neurons; Neuroprotective Agents; Pyramidal Cells; Quinolinic Acid; Rats; Sulfonamides; Thiazoles | 2002 |